MT-ND6 and neoplasm: Using a cytoplasmic hybrid technology with several tumor cell lines, Ishikawa et al. [19] reported that ND6 missense mutation contribute to tumor cell metastasis in mouse fibrosarcoma, lung carcinoma and colon cancer.